Pediatrix Medical Group, Inc. (MD) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-20.8%

$24.46

vs $30.88 price

Levered DCF

$37.84

After debt service

Piotroski score

7 / 9

Strong

Altman Z-score

2.44

Grey zone

Rating

B+

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	11.03×	-11.03×	-12.74×	18.58×	17.9×	-2.64×	-1.56×	11.19×
P/B	2.11×	1.43×	0.9×	1.38×	2.62×	2.81×	1.56×	0.97×
P/S	0.95×	0.54×	0.38×	0.63×	1.23×	1.21×	1.32×	0.82×
EV / EBITDA	7.69×	-53.77×	46.6×	12.38×	12.83×	19.04×	19.77×	10.56×
Gross margin	24.7%	22.6%	21.1%	23.7%	26.9%	25.9%	28.3%	27.1%
Operating margin	12.1%	-3.4%	0.4%	8.8%	10.6%	5.7%	9.7%	12.2%
Net margin	8.6%	-4.9%	-3.0%	3.4%	6.9%	-45.9%	-84.2%	7.4%
Current ratio	1.66×	1.47×	1.24×	1×	1.97×	3.49×	1.35×	1.4×
Debt / equity	0.76×	0.87×	0.83×	0.8×	1.19×	2.41×	1.2×	0.64×
Interest coverage	6.43×	-1.69×	0.17×	4.35×	2.95×	0.89×	1.44×	4.8×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	19.1%	-13.0%	-7.1%	7.4%	14.6%	-106.6%	-99.9%	8.7%
Return on invested capital	9.7%	-3.8%	0.4%	6.8%	7.0%	-4.5%	3.4%	5.9%
Return on assets	7.4%	-4.6%	-2.7%	2.8%	4.8%	-23.8%	-36.1%	4.5%
Free cash flow yield	13.9%	16.9%	13.6%	11.1%	1.9%	8.4%	14.5%	8.0%
Earnings yield	9.1%	-9.1%	-7.9%	5.4%	5.6%	-37.9%	-64.0%	8.9%
Enterprise value	$2.1B	$1.5B	$1.4B	$1.9B	$3B	$2.8B	$4B	$4.9B
Net debt / EBITDA	1.04×	-15.24×	21.03×	4.51×	2.87×	4.66×	8.28×	4.14×
Cash conversion cycle (days)	37	39	43	47	51	34	79	46